Group One Trading, L.P. Tarsus Pharmaceuticals, Inc. Transaction History
Group One Trading, L.P.
- $2.2 Billion
- Q1 2025
A detailed history of Group One Trading, L.P. transactions in Tarsus Pharmaceuticals, Inc. stock. As of the latest transaction made, Group One Trading, L.P. holds 571 shares of TARS stock, worth $25,152. This represents 0.0% of its overall portfolio holdings.
Number of Shares
571Holding current value
$25,152% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding TARS
# of Institutions
201Shares Held
44.5MCall Options Held
19.9KPut Options Held
7.6K-
Rtw Investments, LP New York, NY3.32MShares$146 Million2.79% of portfolio
-
Black Rock Inc. New York, NY3.27MShares$144 Million0.0% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY2.61MShares$115 Million6.87% of portfolio
-
Jennison Associates LLC2.49MShares$110 Million0.09% of portfolio
-
Tang Capital Management LLC San Diego, CA2.45MShares$108 Million8.19% of portfolio
About Tarsus Pharmaceuticals, Inc.
- Ticker TARS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,658,500
- Market Cap $1.17B
- Description
- Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as...